Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raloxifene: risks and benefits.

E Barrett-Connor1

  • 1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla 92093, USA. ebarrettconnor@ucsd.edu

Annals of the New York Academy of Sciences
|January 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Sex and Age Differences in the Association of Blood Pressure and Hypertension with Cognitive Function in the Elderly: The Rancho Bernardo Study.

The journal of prevention of Alzheimer's disease·2017
Same author

Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Kyphosis and Sleep Characteristics in Older Persons: The Rancho Bernardo Study.

Journal of sleep disorders and management·2017
Same author

Blood pressure trajectories in relation to cardiovascular mortality: The Rancho Bernardo Study.

Journal of human hypertension·2017
Same author

Association between Dietary Sodium Intake and Cognitive Function in Older Adults.

The journal of nutrition, health & aging·2017
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Raloxifene offers estrogen replacement benefits without the risks, unlike traditional hormone replacement therapy (HRT). This review examines clinical evidence to aid postmenopausal women

Area of Science:

  • Pharmacology
  • Endocrinology
  • Women's Health

Background:

  • Selective estrogen receptor modulators (SERMs) aim to replicate estrogen's benefits while mitigating risks.
  • Postmenopausal hormone therapy (HT) carries known risks, prompting the search for safer alternatives.
  • Raloxifene is a SERM developed for postmenopausal women.

Purpose of the Study:

  • To review clinical trial data on raloxifene's benefits and risks.
  • To compare raloxifene with hormone replacement therapy (HRT).
  • To inform treatment choices for postmenopausal women.

Main Methods:

  • Systematic review of clinical trial evidence.
  • Comparative analysis of raloxifene versus HRT outcomes.
  • Evaluation of safety and efficacy data.

Related Experiment Videos

Main Results:

  • Evidence on raloxifene's specific benefits and adverse events.
  • Comparative risk-benefit profiles of raloxifene and HRT.
  • Data relevant to clinical decision-making for postmenopausal care.

Conclusions:

  • Raloxifene presents a distinct profile compared to HRT.
  • Clinical evidence guides the selection of raloxifene for specific patient needs.
  • Understanding raloxifene's risks and benefits is crucial for postmenopausal women's health choices.